Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,051 | 77,330 | 95,120 | 52,224 | 37,329 |
| Marketable Securities | 72,814 | 47,641 | 36,268 | 13,975 | 16,135 |
| Receivables | 4,470 | 5,219 | 11,280 | N/A | N/A |
| Other current assets | 1,716 | 1,402 | 1,093 | 2,133 | 1,923 |
| TOTAL | $133,051 | $131,592 | $143,761 | $68,332 | $55,387 |
| Non-Current Assets | |||||
| PPE Net | 1,532 | 1,827 | 2,085 | 2,236 | 2,695 |
| Investments And Advances | 3,739 | 10,181 | 2,869 | 2,988 | 6,411 |
| Other Non-Current Assets | 6,102 | 6,333 | 6,329 | 6,327 | 6,325 |
| TOTAL | $11,373 | $18,341 | $11,283 | $11,551 | $15,431 |
| Total Assets | $144,424 | $149,933 | $155,044 | $79,883 | $70,818 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 810 | 912 | 640 | 539 | 2,188 |
| Accrued Expenses | 8,603 | 8,334 | 7,172 | 6,428 | 6,240 |
| Other current liabilities | N/A | N/A | N/A | 1,481 | 1,436 |
| TOTAL | $52,777 | $53,184 | $52,123 | $18,630 | $19,961 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 39,979 | 39,891 | 39,861 | 5,813 | 5,808 |
| Other Non-Current Liabilities | 1,514 | 1,425 | 1,252 | 1,079 | 906 |
| TOTAL | $72,302 | $80,102 | $90,509 | $44,532 | $46,903 |
| Total Liabilities | $125,079 | $133,286 | $142,632 | $63,162 | $66,864 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,887 | 54,862 | 54,842 | 54,832 | 44,062 |
| Common Shares | 55 | 55 | 55 | 55 | 44 |
| Retained earnings | -762,269 | -764,756 | -768,089 | -762,937 | -754,301 |
| Other shareholders' equity | -48 | 696 | 691 | 694 | 1,209 |
| TOTAL | $19,345 | $16,647 | $12,412 | $16,721 | $3,954 |
| Total Liabilities And Equity | $144,424 | $149,933 | $155,044 | $79,883 | $70,818 |